These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 27732819)

  • 41. Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus.
    Bixler SL; Bocan TM; Wells J; Wetzel KS; Van Tongeren SA; Dong L; Garza NL; Donnelly G; Cazares LH; Nuss J; Soloveva V; Koistinen KA; Welch L; Epstein C; Liang LF; Giesing D; Lenk R; Bavari S; Warren TK
    Antiviral Res; 2018 Mar; 151():97-104. PubMed ID: 29289666
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative Evaluation of the Diagnostic Performance of the Prototype Cepheid GeneXpert Ebola Assay.
    Jansen van Vuren P; Grobbelaar A; Storm N; Conteh O; Konneh K; Kamara A; Sanne I; Paweska JT
    J Clin Microbiol; 2016 Feb; 54(2):359-67. PubMed ID: 26637383
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of a point-of-care blood test for identification of Ebola virus disease at Ebola holding units, Western Area, Sierra Leone, January to February 2015.
    Walker NF; Brown CS; Youkee D; Baker P; Williams N; Kalawa A; Russell K; Samba AF; Bentley N; Koroma F; King MB; Parker BE; Thompson M; Boyles T; Healey B; Kargbo B; Bash-Taqi D; Simpson AJ; Kamara A; Kamara TB; Lado M; Johnson O; Brooks T
    Euro Surveill; 2015 Mar; 20(12):. PubMed ID: 25846490
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of Diagnostic Findings From the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015.
    Kerber R; Krumkamp R; Diallo B; Jaeger A; Rudolf M; Lanini S; Bore JA; Koundouno FR; Becker-Ziaja B; Fleischmann E; Stoecker K; Meschi S; Mély S; Newman EN; Carletti F; Portmann J; Korva M; Wolff S; Molkenthin P; Kis Z; Kelterbaum A; Bocquin A; Strecker T; Fizet A; Castilletti C; Schudt G; Ottowell L; Kurth A; Atkinson B; Badusche M; Cannas A; Pallasch E; Bosworth A; Yue C; Pályi B; Ellerbrok H; Kohl C; Oestereich L; Logue CH; Lüdtke A; Richter M; Ngabo D; Borremans B; Becker D; Gryseels S; Abdellati S; Vermoesen T; Kuisma E; Kraus A; Liedigk B; Maes P; Thom R; Duraffour S; Diederich S; Hinzmann J; Afrough B; Repits J; Mertens M; Vitoriano I; Bah A; Sachse A; Boettcher JP; Wurr S; Bockholt S; Nitsche A; Županc TA; Strasser M; Ippolito G; Becker S; Raoul H; Carroll MW; De Clerck H; Van Herp M; Sprecher A; Koivogui L; Magassouba N; Keïta S; Drury P; Gurry C; Formenty P; May J; Gabriel M; Wölfel R; Günther S; Di Caro A
    J Infect Dis; 2016 Oct; 214(suppl 3):S250-S257. PubMed ID: 27638946
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heterogeneity in District-Level Transmission of Ebola Virus Disease during the 2013-2015 Epidemic in West Africa.
    Krauer F; Gsteiger S; Low N; Hansen CH; Althaus CL
    PLoS Negl Trop Dis; 2016 Jul; 10(7):e0004867. PubMed ID: 27434164
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epidemiological characteristics, clinical manifestations, and treatment outcome of 139 paediatric Ebola patients treated at a Sierra Leone Ebola treatment center.
    Kangbai JB; Heumann C; Hoelscher M; Sahr F; Froeschl G
    BMC Infect Dis; 2019 Jan; 19(1):81. PubMed ID: 30678649
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ribavirin does not potentiate favipiravir antiviral activity against Ebola virus in non-human primates.
    Madelain V; Duthey A; Mentré F; Jacquot F; Solas C; Lacarelle B; Vallvé A; Barron S; Barrot L; Mundweiler S; Thomas D; Carbonnelle C; Raoul H; de Lamballerie X; Guedj J
    Antiviral Res; 2020 May; 177():104758. PubMed ID: 32135218
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Successful Implementation of a Multicountry Clinical Surveillance and Data Collection System for Ebola Virus Disease in West Africa: Findings and Lessons Learned.
    Roshania R; Mallow M; Dunbar N; Mansary D; Shetty P; Lyon T; Pham K; Abad M; Shedd E; Tran AM; Cundy S; Levine AC
    Glob Health Sci Pract; 2016 Sep; 4(3):394-409. PubMed ID: 27688716
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ebola virus disease - pathogenesis, clinical presentation and management.
    Bociaga-Jasik M; Piatek A; Garlicki A
    Folia Med Cracov; 2014; 54(3):49-55. PubMed ID: 25694095
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preliminary Evaluation of the Effect of Investigational Ebola Virus Disease Treatments on Viral Genome Sequences.
    Whitmer SL; Albariño C; Shepard SS; Dudas G; Sheth M; Brown SC; Cannon D; Erickson BR; Gibbons A; Schuh A; Sealy T; Ervin E; Frace M; Uyeki TM; Nichol ST; Ströher U
    J Infect Dis; 2016 Oct; 214(suppl 3):S333-S341. PubMed ID: 27521366
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ebola virus disease in children during the 2014-2015 epidemic in Guinea: a nationwide cohort study.
    Chérif MS; Koonrungsesomboon N; Kassé D; Cissé SD; Diallo SB; Chérif F; Camara F; Koné A; Avenido EF; Diakité M; Diallo MP; Le Gall E; Cissé M; Karbwang J; Hirayama K
    Eur J Pediatr; 2017 Jun; 176(6):791-796. PubMed ID: 28444452
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical Laboratory Values as Early Indicators of Ebola Virus Infection in Nonhuman Primates.
    Reisler RB; Yu C; Donofrio MJ; Warren TK; Wells JB; Stuthman KS; Garza NL; Vantongeren SA; Donnelly GC; Kane CD; Kortepeter MG; Bavari S; Cardile AP
    Emerg Infect Dis; 2017 Aug; 23(8):1316-1324. PubMed ID: 28726603
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted.
    Nguyen TH; Guedj J; Anglaret X; Laouénan C; Madelain V; Taburet AM; Baize S; Sissoko D; Pastorino B; Rodallec A; Piorkowski G; Carazo S; Conde MN; Gala JL; Bore JA; Carbonnelle C; Jacquot F; Raoul H; Malvy D; de Lamballerie X; Mentré F;
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005389. PubMed ID: 28231247
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of Referral Pathway on Ebola Virus Disease Case-Fatality Rate and Effect of Survival Selection Bias.
    Rudolf F; Damkjær M; Lunding S; Dornonville de la Cour K; Young A; Brooks T; Sesay T; Salam AP; Mishra S; Storgaard M
    Emerg Infect Dis; 2017 Apr; 23(4):597-600. PubMed ID: 28322693
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inpatient signs and symptoms and factors associated with death in children aged 5 years and younger admitted to two Ebola management centres in Sierra Leone, 2014: a retrospective cohort study.
    Shah T; Greig J; van der Plas LM; Achar J; Caleo G; Squire JS; Turay AS; Joshy G; D'Este C; Banks E; Vogt F; Lokuge K
    Lancet Glob Health; 2016 Jul; 4(7):e495-501. PubMed ID: 27340004
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intracellular conversion and in vivo dose response of favipiravir (T-705) in rodents infected with Ebola virus.
    Bixler SL; Bocan TM; Wells J; Wetzel KS; Van Tongeren SA; Garza NL; Donnelly G; Cazares LH; Soloveva V; Welch L; Epstein C; Liang LF; Giesing D; Lenk R; Bavari S; Warren TK
    Antiviral Res; 2018 Mar; 151():50-54. PubMed ID: 29289664
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structures of protective antibodies reveal sites of vulnerability on Ebola virus.
    Murin CD; Fusco ML; Bornholdt ZA; Qiu X; Olinger GG; Zeitlin L; Kobinger GP; Ward AB; Saphire EO
    Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17182-7. PubMed ID: 25404321
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical Features of and Risk Factors for Fatal Ebola Virus Disease, Moyamba District, Sierra Leone, December 2014-February 2015.
    Haaskjold YL; Bolkan HA; Krogh KØ; Jongopi J; Lundeby KM; Mellesmo S; Garcés PS; Jøsendal O; Øpstad Å; Svensen E; Fuentes LM; Kamara AS; Riera M; Arranz J; Roberts DP; Stamper PD; Austin P; Moosa AJ; Marke D; Hassan S; Eide GE; Berg Å; Blomberg B
    Emerg Infect Dis; 2016 Sep; 22(9):1537-44. PubMed ID: 27268303
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Age and Ebola viral load correlate with mortality and survival time in 288 Ebola virus disease patients.
    Li J; Duan HJ; Chen HY; Ji YJ; Zhang X; Rong YH; Xu Z; Sun LJ; Zhang JY; Liu LM; Jin B; Zhang J; Du N; Su HB; Teng GJ; Yuan Y; Qin EQ; Jia HJ; Wang S; Guo TS; Wang Y; Mu JS; Yan T; Li ZW; Dong Z; Nie WM; Jiang TJ; Li C; Gao XD; Ji D; Zhuang YJ; Li L; Wang LF; Li WG; Duan XZ; Lu YY; Sun ZQ; Kanu ABJ; Koroma SM; Zhao M; Ji JS; Wang FS
    Int J Infect Dis; 2016 Jan; 42():34-39. PubMed ID: 26523640
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predicting Ebola Severity: A Clinical Prioritization Score for Ebola Virus Disease.
    Hartley MA; Young A; Tran AM; Okoni-Williams HH; Suma M; Mancuso B; Al-Dikhari A; Faouzi M
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005265. PubMed ID: 28151955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.